-
Map** fNIRS to fMRI with Neural Data Augmentation and Machine Learning Models
Authors:
Jihyun Hur,
Jaeyeong Yang,
Hoyoung Doh,
Woo-Young Ahn
Abstract:
Advances in neuroimaging techniques have provided us novel insights into understanding how the human mind works. Functional magnetic resonance imaging (fMRI) is the most popular and widely used neuroimaging technique, and there is growing interest in fMRI-based markers of individual differences. However, its utility is often limited due to its high cost and difficulty acquiring from specific popul…
▽ More
Advances in neuroimaging techniques have provided us novel insights into understanding how the human mind works. Functional magnetic resonance imaging (fMRI) is the most popular and widely used neuroimaging technique, and there is growing interest in fMRI-based markers of individual differences. However, its utility is often limited due to its high cost and difficulty acquiring from specific populations, including children and infants. Surrogate markers, or neural correlates of fMRI markers, would have important practical implications, but we have few stand-alone predictors for the fMRI markers. Here, using machine learning (ML) models and data augmentation, we predicted well-validated fMRI markers of human cognition from multivariate patterns of functional near-infrared spectroscopy (fNIRS), a portable and relatively inexpensive optical neuroimaging technique. We recruited 50 human participants who performed two cognitive tasks (stop signal task and probabilistic reversal learning task), while neural activation was measured with either fNIRS or fMRI at each of the total two visits. Using ML models and data augmentation, we could predict the well-established fMRI markers of response inhibition or prediction error signals from 48-channel fNIRS activation in the prefrontal cortex. These results suggest that fNIRS might offer a surrogate marker of fMRI activation, which would broaden our understanding of various populations, including infants.
△ Less
Submitted 13 June, 2022;
originally announced June 2022.
-
Ontology-based systematic classification and analysis of coronaviruses, hosts, and host-coronavirus interactions towards deep understanding of COVID-19
Authors:
Hong Yu,
Li Li,
Hsin-hui Huang,
Yang Wang,
Yingtong Liu,
Edison Ong,
Anthony Huffman,
Tao Zeng,
**gsong Zhang,
Pengpai Li,
Zhi** Liu,
Xiangyan Zhang,
Xianwei Ye,
Samuel K. Handelman,
Gerry Higgins,
Gilbert S. Omenn,
Brian Athey,
Junguk Hur,
Luonan Chen,
Yongqun He
Abstract:
Given the existing COVID-19 pandemic worldwide, it is critical to systematically study the interactions between hosts and coronaviruses including SARS-Cov, MERS-Cov, and SARS-CoV-2 (cause of COVID-19). We first created four host-pathogen interaction (HPI)-Outcome postulates, and generated a HPI-Outcome model as the basis for understanding host-coronavirus interactions (HCI) and their relations wit…
▽ More
Given the existing COVID-19 pandemic worldwide, it is critical to systematically study the interactions between hosts and coronaviruses including SARS-Cov, MERS-Cov, and SARS-CoV-2 (cause of COVID-19). We first created four host-pathogen interaction (HPI)-Outcome postulates, and generated a HPI-Outcome model as the basis for understanding host-coronavirus interactions (HCI) and their relations with the disease outcomes. We hypothesized that ontology can be used as an integrative platform to classify and analyze HCI and disease outcomes. Accordingly, we annotated and categorized different coronaviruses, hosts, and phenotypes using ontologies and identified their relations. Various COVID-19 phenotypes are hypothesized to be caused by the backend HCI mechanisms. To further identify the causal HCI-outcome relations, we collected 35 experimentally-verified HCI protein-protein interactions (PPIs), and applied literature mining to identify additional host PPIs in response to coronavirus infections. The results were formulated in a logical ontology representation for integrative HCI-outcome understanding. Using known PPIs as baits, we also developed and applied a domain-inferred prediction method to predict new PPIs and identified their pathological targets on multiple organs. Overall, our proposed ontology-based integrative framework combined with computational predictions can be used to support fundamental understanding of the intricate interactions between human patients and coronaviruses (including SARS-CoV-2) and their association with various disease outcomes.
△ Less
Submitted 31 May, 2020;
originally announced June 2020.
-
Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data
Authors:
Zhihan Wang,
Kai Guo,
Pan Gao,
Qinqin Pu,
Min Wu,
Changlong Li,
Junguk Hur
Abstract:
Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. There is no specific drug for COVID-19, highlighting the urgent need for the development of effective therapeutics. To identify potentially repurposable drugs, we employed a systematic approach to mine candidates from U.S. FDA-approved drugs and preclinical small-mol…
▽ More
Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. There is no specific drug for COVID-19, highlighting the urgent need for the development of effective therapeutics. To identify potentially repurposable drugs, we employed a systematic approach to mine candidates from U.S. FDA-approved drugs and preclinical small-molecule compounds by integrating the gene expression perturbation data for chemicals from the Library of Integrated Network-Based Cellular Signatures project with a publicly available single-cell RNA sequencing dataset from mild and severe COVID-19 patients. We identified 281 FDA-approved drugs that have the potential to be effective against SARS-CoV-2 infection, 16 of which are currently undergoing clinical trials to evaluate their efficacy against COVID-19. We experimentally tested the inhibitory effects of tyrphostin-AG-1478 and brefeldin-a on the replication of the single-stranded ribonucleic acid (ssRNA) virus influenza A virus. In conclusion, we have identified a list of repurposable anti-SARS-CoV-2 drugs using a systems biology approach.
△ Less
Submitted 4 December, 2020; v1 submitted 15 May, 2020;
originally announced May 2020.
